Strategic partnerships Epilepsy Ireland actively pursues collaborations (e.g., with Dublin City University on EpiBreak and Connelly Partners for awareness campaigns), indicating a receptiveness to co-funded programs, research partnerships, and joint awareness initiatives that can expand reach and funding opportunities.

Research and innovation The organization is engaging in cutting-edge initiatives like nasal-delivery nano-carriers for anti-seizure medication, signaling a potential interest in technology providers, research grants, and translational science partnerships that align with biomedical innovation and patient outcomes.

Membership expansion Launch of a new membership structure in 2026 suggests a push to grow community engagement and recurring support, presenting opportunities for membership platforms, CRM enhancements, donor engagement tools, and tiered sponsorship packages.

Public awareness and education Activities around public policy, advocacy, and seizure awareness campaigns indicate demand for communications, content creation, training programs, and event management services to amplify impact and drive support.

Funding and governance With a small (<1M USD) revenue base and emphasis on governance and diversified income in their strategic plan, Epilepsy Ireland may be receptive to tailored fundraising solutions, grant management, and cost-efficient technology to optimize resource allocation.